AGL vs MD

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 21, 2026

AGL

35.2
AI Score
VS
MD Wins

MD

41.3
AI Score

Investment Advisor Scores

AGL

35score
Recommendation
AVOID NEW MONEY

MD

41score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric AGL MD Winner
Forward P/E 178.5714 9.2937 MD
PEG Ratio 0 0.2433 Tie
Revenue Growth 7.2% 4.0% AGL
Earnings Growth 301.0% 6.5% AGL
Tradestie Score 35.2/100 41.3/100 MD
Profit Margin -3.9% 9.0% MD
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY HOLD MD

Relative Price Performance (Last 90 Days)

AGL 1M: +18.9% · 3M: -8.4% MD 1M: +14.0% · 3M: +11.9%

Current Technical Phase

AGL

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 55

RSI (14): 55.0 · Price: $90.16

MD

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (1.1% over 20 days), RSI 71

RSI (14): 70.6 · Price: $29.25

Fundamentals Snapshot

Metric AGL MD
Market Cap — —
Forward P/E 38.2 12.1
Trailing P/E — 13.4
Revenue (TTM) — —
Revenue Growth 0.1% 0.0%
Gross Margin 0.0% 0.3%
Operating Margin 0.0% 0.1%
EPS -15.41 2.09
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, MD is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.